Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK580416

Clinical trial NCT00680485 · TERMINATED

Trial details

NCT number: NCT00680485
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infection Infections, Bacterial

Start date: 2007-06-01
Primary completion: 2007-10-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.